Peptides

HCV NS3/4A Protease Substrate - 1 mg

$872.00
Check your price
  • Cat.Number : AS-60798
  • Availability :
    In stock

Quantity

A highly sensitive FRET substrate for assaying HCV (Hepatitis C Virus) NS3/4A protease activity. It detects < 0.1pmol of HCV NS3/4A protease. Upon cleavage of this substrate, fluorescence can be monitored at Abs/Em = 490/512 nm.

Specifications

Chemistry
Sequence one letter code
  • Ac-DE-Dap(QXL®520)-EE-Abu-ψ-[COO]AS-C(5-FAMsp)-NH2
Sequence three letter code
  • Ac-Asp-Glu-Dap(QXL®520)-Glu-Glu-Abu-ψ-[COO]-Ala -Ser-Cys(5-FAMsp)-NH2
Molecular Mass/ Weight
  • 1913.8
Modification
Conjugation
  • Unconjugated
Quantity & Purity
Purity
  • Peak Area by HPLC ≥95%
Storage & stability
Form
  • Lyophilized
Storage Conditions
  • - 20 °C
Activity
Application
Biomarker Target
Research Area
Sub-category Research Area
Usage
  • Research use
Source
Source / Species
  • HCV

You may also be interested in the following product(s)

IMG-EN-AS-61017-10-01.JPG

HCV NS3/4A protease genotype 1b, recombinant

Cat.Number : AS-61017-5
$285.00 Excl. Tax
IMG-EN-AS-71145-01.jpg

SensoLyte® 520 HCV Protease Assay Kit Fluorimetric - 1 kit

Cat.Number : AS-71145
$582.00 Excl. Tax

Citations

Identification of hepatitis C virus inhibitors targeting different aspects of infection using a cell-based assay.

Antimicrob Agents Chemother . 2012 Sep 04 ; 56(12) 6109 | DOI : 10.1128/AAC.01413-12

  • X. Yu

Development of a cell-based hepatitis C virus (HCV) infection FRET assay for high throughput antiviral compound screening.

Antimicrob Agents Chemo . 2009 Jul 20 ; 53(10) 4311 | DOI : 10.1128/AAC.00495-09.

  • X. Yu

Preclinical Characteristics of the Hepatitis C Virus NS3/4A Protease Inhibitor ITMN-191 (R7227).

Antimicrob Agents Chemother . 2008 Sep 29 ; 52(12) 4432 | DOI : 10.1128/AAC.00699-08

  • S. Seiwert

Biliverdin and Heme Oxygenase Antibiral Activity Against Hepatitis C Virus.

Ann Hepatol . 2011 Jan 01 ; 10(1) 105 | DOI : PMID: 21301021

  • Y. Gutierrez-Grobe

References

Understanding Biology Using Peptides

Ameri Pept Soci . 2005 Jan 01 ; 867 844

  • XH. Tong